Next Article in Journal
Enhanced Patient-Centricity: How the Biopharmaceutical Industry Is Optimizing Patient Care through AI/ML/DL
Previous Article in Journal
Obstructive Giant Inflammatory Polyposis as a First Manifestation of Crohn’s Disease: A Case Report
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Parental Reminder Strategies and the Cost Implication for Improved Immunisation Outcomes: A Systematic Review and Meta-Analysis

by
Hamina Dathini
1,2,
Siti Khuzaimah Ahmad Sharoni
1,* and
Kever Teriyla Robert
2
1
Centre for Nursing Studies, Faculty of Health Sciences, Universiti Teknologi MARA, UiTM Selangor, Puncak Alam Campus, Selangor 42300, Malaysia
2
Department of Nursing Science, Faculty of Allied Health, University of Maiduguri, Maiduguri 600104, Nigeria
*
Author to whom correspondence should be addressed.
Healthcare 2022, 10(10), 1996; https://doi.org/10.3390/healthcare10101996
Submission received: 30 August 2022 / Revised: 3 October 2022 / Accepted: 3 October 2022 / Published: 11 October 2022

Abstract

:
Getting children vaccinated amidst prevailing barriers to immunisation has been challenging in both developed and developing countries. To address these problems, studies on parental reminder strategies were conducted to improve immunisation outcomes in children. These led to the development of different parental reminder interventions. This review systematically reviews different parental interventions and their cost implication for improved immunisations. Five online databases; Medline Complete, the Cumulative Index for Nursing and Allied Health Literature [CINAHL], Academic search premier, SPORTDiscus, and Health Source Nursing/Academic were searched using search terms. A total of 24 articles that met the inclusion criteria were included in this review. Studies that provided sufficient information were included for meta-analysis using Comprehensive Meta-Analysis version three, while narrative synthesis was used for the other studies. Results indicate that a heterogeneous and low-quality certainty of evidence on parental voice calls (OR 4.752, 95% CI 1.846–12.231, p = 0.001) exists in improving immunisation coverage. Regarding immunisation timeliness, a high-quality certainty of evidence on Short Message Services (SMS)-delivered health education messages (OR 2.711 95% CI 1.387–5.299, p = 0.004) had more effect on timely immunisation uptake. The average cost of SMS-delivered parental reminder interventions for improved immunisation outcomes was USD 0.50. The study concludes that mobile technology is a promising, cost-effective strategy for improved immunisation outcomes.

1. Introduction

Vaccines are either DNA recombinant, inactivated or live attenuated antigens administered to an individual to elicit an endogenous response against subsequent invasion by the pathogen; recently, blueprints of the antigen are also used [1,2]. Vaccines are effective interventions for reducing infant and child mortality [3,4]. Hence, Lwembe et al. [5] reveal that vaccination is a cost-effective global public health intervention for reducing the prevalence of infectious diseases, especially in children. In the United States, for example, children are expected to be vaccinated against 16 childhood diseases to reduce morbidity, disability, and death from infectious diseases [6].
It is estimated that over 23 million children worldwide are inadequately immunized, particularly in the first year of life when most vaccines are administered; as a result, approximately 1.5 million vaccine-preventable deaths occur [5,7]. Measles, for example, accounted for over 140,000 childhood deaths in 2018 alone, and within three years, immunisation against measles prevented over 23 million childhood deaths [8]. Accordingly, childhood vaccinations effectively prevent about 22% of death from all causes of infectious diseases in children [9].
In addition to preventing under-five deaths, vaccinations are a cost-effective strategy compared to the treatment cost of vaccine-preventable diseases [10]. For instance, evidence has shown that for every USD 1 spent on measles immunisation in low and middle-income countries, an estimated USD 76 is saved [10]. In this regard, Orenstein and Ahmed [11] reported a return on investment of USD 586 billion for every USD 34 billion of direct costs of vaccination in developing countries, with a net direct and indirect cost of USD 1.53 trillion. This is huge. Similarly, in a high-income country, the United States, an estimate shows that the immunisation program saved about USD 69 billion in direct and indirect costs [6].
Active parental involvement in immunisation services is one of the most significant challenges to adequate immunisation coverage [11]. Several factors impede the active involvement of parents in immunisation services, they are negligence, acceptance, attitudes and forgetfulness [9,11]. Of these factors, evidence suggests that forgetfulness of scheduled vaccination appointments is the most prevalent of the impeding factors [12,13]. To address these problems, studies on parental reminder strategies were conducted to find an effective strategy to motivate parents to vaccinate their children. These led to the development of different parental reminder interventions. It is therefore paramount to systematically review these studies to determine the most effective strategy for improved childhood immunisation outcomes.
There are a few systematic reviews conducted in this regard; some were based on the effect of parental reminders in developing countries [14,15], others were conducted a long time ago, and new evidence has emerged [16] or narrowed to a specific intervention [15,17,18]. Others targeted adolescent or adult populations, not children under five [3,7]. Therefore, studies conducted in high- and low-income countries need to be evaluated as there is new evidence and to systematically review the cost implications of delivering the parental reminder strategies. Hence, this systematic review could provide evidence of different parental reminder strategies and cost implications for enhanced coverage and timeliness of immunisation.

Objectives

  • To determine the effective parental strategy for improving coverage of childhood immunisation;
  • To determine the effective parental strategy for enhancing the timeliness of childhood immunisation;
  • To determine the cost associated with delivering parental strategies for improved immunisation uptake.

2. Materials and Methods

The Preferred Reporting Items for Systematic reviews and Meta-Analysis [PRISMA] was developed and introduced by Cochrane in 2009 to ensure consistency in the reporting of systematic reviews [19]. However, the PRISMA was updated and expanded in 2020 to overcome the limitations of the 2009 PRISMA [20]. Therefore, the 2020 version of PRISMA was adopted for this review. The PRISMA 2020 checklist can be accessed at https://prisma-statement.org/PRISMAStatement/Checklist.aspx (accessed on 29 August 2022).

2.1. Eligibility Criteria

The inclusion and exclusion criteria used for this review is as shown on Table 1 below.

2.2. Information Sources

The systematic search for articles was conducted from Wednesday 29 June to Thursday 7 July 2022. Articles searches were conducted using five online databases: Medline Complete, the Cumulative Index for Nursing and Allied Health Literature [CINAHL], Academic search premier, SPORTDiscus and Health Source Nursing/Academic.

2.3. Search Strategy and Selection Process

The search for articles was performed using appropriate MeSH and keywords in Medline Complete, CINAHL, SPORTDiscus, Health Source Nursing/Academic and Academic search premier. Boolean operators such as “AND” and “OR” and wild cards “*” were used in addition to search terms for search in the databases. The search terms used are: (‘‘parental reminder’’ OR ‘‘reminder system*’’ OR ‘‘retrieval strateg*’’ OR ‘‘recall initiative*’’) AND (monitor* OR improv* OR impact* OR affect* OR effect* OR determin* OR assess* OR evaluat* OR measur* OR influenc*) AND (‘‘immunization’’ OR ‘‘immunization program*’’ OR ‘‘immunization status’’ OR ‘‘immunization level’’ OR ‘‘immunization performance’’). Article search was limited to online databases of articles published between 2015 to 2022 to enable researchers to find current evidence on the strategies investigated on parental reminders for enhanced immunisation outcomes. The reference list of the systematic review was also performed to identify literature that might have been missed.

2.4. Study Selection

The Prisma template guided study selection. The databases were synchronously searched using Ebscohost. The system automatically removes duplicates. Subsequently, the inclusion and exclusion criteria of the study guided the screening of the title and abstract. After that, full-text screening was conducted to determine eligible studies. The study selection was independently made by two researchers (D.H. and S.K.A.S.); where there were disagreements, a consensus was used to resolve them.

2.5. Data Collection Process

The data collection process of the eligible studies was performed independently by D.H. and verified by S.K.A.S. using spreadsheets.

2.6. Data Items

Items to be extracted from studies are critical for a successful review, and it is therefore essential for researchers to carefully determine items needed for the systematic review and conscientiously extract them [21]. The information extracted for this review includes the author, year of publication, study participants, sample size, intervention(s) for each intervention category, comparator and their sample size, research design, vaccine type and country. Others include the dose of the intervention, which includes the frequency and course of the intervention, outcomes, instrument for data collection and results. Two researchers were involved in the data extraction process to minimize errors during the data extraction. Firstly, D.H. performed the initial data extraction, and S.K.A.S. verified to ensure the correct data were extracted. The table of data extraction is presented in Table A1.

2.7. Risk of Bias in Individual Studies

The selected 24 articles that met the inclusion criteria were assessed for risk of bias. Two study designs were generally included in the review, randomized control trials and quasi-experimental studies. Due to the two types of studies included in the review, the Physiotherapy Evidence Database Scale (PEDro scale) and Crowe Critical Appraisal Tool (CCAT) were used for bias assessment for randomised control trials (RCT) and quasi-experimental studies, respectively. They were chosen because of their good validity, reliability and acceptability across the globe as an easy-to-use tool with reliable and meaningful practical application [22]. The PEDro scale has 11 items scored as either Yes = 1 point or No/not sure = 0 [23]. Item one denotes the study’s eligibility [24]. The score is obtained by summing items 2 to 11 and assessed out of 10, while the internal validity is obtained by summing items 2 to 9 marked out of 8. Lastly, the reporting subscale is obtained by adding items 10 and 11, rated out of 2 [24]. Interpretation of the PEDro scale is 0–3 = poor, 4–5 fair, 6–8 good and 9–10 = excellent. The higher the score, the better the article. For this study, any article that ranges from a score of 4 (fair) to 10 (excellent) was included [23]. Table 2 shows the summary findings of the risk of bias of all RCTs included in this review. On the other hand, quasi-experimental studies included in the review were assessed using CCAT. The CCAT assesses eight components of a research article and is scored from zero to five. The total score is obtained by summing items one to eight and is scored out of 40. The final score is then converted and presented as a percentage by dividing the total score by 40 and multiplying by 100 [25]. Although Crowe left open the interpretation of the score to the assessor to make based on individual study requirements, Salihu et al. [24], in their review, revealed a score of <50 as poor and >50 as good for the study to be rejected or accepted accordingly. This review hence adopted it. Table 3 shows the risk of bias in the studies using the CCAT. Two independent reviewers performed the quality appraisal, D.H and S.K.A.S., a third independent reviewer resolved disparity.
Table 2. Quality appraisal of RCT articles using the PEDro scale.
Table 2. Quality appraisal of RCT articles using the PEDro scale.
AuthorYearEligibilityRandomised AllocationConcealed AllocationSimilarity at BaselineBlinding of ParticipantsBlinding of TherapistBlinding of AssessorDropoutIntention to TreatGroup ComparisonPMVDTotal Score (10)Internal Validity
(8)
SUBSCALE (2)InterpretationDecision
Nagar et al.[7]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
Mekonnen et al.[9]YesYesYesYesNoYesYesYesYesYesYes972ExcellentAccepted
Wallace et al.[12]YesYesNoYesNoNoYesNoYesYe sYes642GoodAccepted
Niederhauser et al.[26]YesYesNoYesNoNoNoYesYesYesNo642GoodAccepted
Busso et al.[27]YesYesNoYesNoNoNoYesYesYesYes642GoodAccepted
Kempe et al.[28]YesNoNoYesNoNoNoYesYesYesYes532FairAccepted
Bangure et al.[29]YesYesYesYesNoNoNoYesYesYesNo651GoodAccepted
Brown et al.[30]YesYesNoYesNoNoNoYesYesYesYes642GoodAccepted
Gibson et al.[31]YesYesYesYesNoNoYesYesYesYesYes871GoodAccepted
Seth et al.[32]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
O’Grady et al.[33]YesYesYesYesNoNoYesYesYesYesYes862GoodAccepted
Domek et al.[34]YesYesYesYesNoYesYesYesYesYesNo871GoodAccepted
Menzies et al.[35]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
Brownstone[36]YesYesNoYesNoNoNoYesNoYesYes532FairAccepted
Siddiqi et al.[37]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
Kagucia[38]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
Kazi et al.[39]YesYesYesYesNoNoNoYesYesYesYes762GoodAccepted
Ekhaguere et al.[40]YesYesYesYesNoYesNoNoYesYesYes752GoodAccepted
Dissieka et al.[41]YesYesYesYesNoNoNoNoNoYesYes532FairAccepted
Hofstetter et al.[42]YesYesYesYesNoNoNoYesYesYesYes752GoodAccepted
Note: PMVD = Point measures and variability data.
Table 3. Crowe critical appraisal for quasi-experimental studies.
Table 3. Crowe critical appraisal for quasi-experimental studies.
NoAuthorYearPreliminaryIntroductionDesignSamplingData CollectionEthical MatterResultsDiscussionTotal Score% ScoreDecision
1Oladepo[13]444334443075Accepted
2Yunusa[15]344344432973Accepted
3Uddin et al.[43]434444343178Accepted
4Ibraheem et al.[44]434343442973Accepted
Salihu et al. [24] reveal a score of <50 as poor and >50 as good for the study to be rejected or accepted accordingly.

2.8. Certainty of Evidence

Certainty of evidence was assessed using the GRADEpro (Grading of Recommendations Assessment, Development and Evaluation) Tool for all the included studies. The funnel plots were used to help in assessing reporting bias.

2.9. Data Analysis

Meta-analysis was conducted for studies that provide sufficient information for inclusion. The original data used for the meta-analysis were a proportion of their respective outcomes. The studies were analyzed using Comprehensive Meta-Analysis software (CMA) version three. The random effect model with odds ratios was used as the pool size measurement. A p-value < 0.05 shows a result as statistically significant. The random effect model was used because of the expected level of heterogeneity of some of the included studies. Additionally, the heterogeneous spread of the odds ratio between research studies was determined by calculating the Q-statistic and I2 to represent the heterogeneous variations between studies expressed as a percentage. In order to interpret the level of significance for clinical decision-making, Hopkin’s scale, a table of effect size and their levels of significance was used [45,46]. See Table A2 for the complete table of effect sizes and their interpretation. In studies that were not analyzed using meta-analysis, a narrative analysis was performed using themes and sub-themes.

3. Results

3.1. Study Selection

The search was conducted in five online databases and turned out the following articles: Medline complete (447), CINAHL (265), SPORTDiscus (08), Health Source Nursing/Academic (74) and Academic search premier (162). A total of 956 research articles were retrieved through online databases. Subsequently, limiters were applied to narrow the search to the desired requirements. Limiters applied were: only studies conducted in English due to the inability of the researchers to interpret and time constraints to get an interpreter, only studies conducted in the past seven years, i.e., 2015 to 2022, to allow for only current pieces of evidence to be included in the review. Another limiter used was only research articles published in academic journals. After applying the limiters, a total of 522 articles were removed. Research articles were further narrowed by 150 after duplicated studies were removed. Hence, 284 articles were left for screening. The screening was conducted based on title, abstract and subsequently, full-length reading. Two hundred thirty-one articles were removed after the title and abstract reading and 32 after full-length, leaving 21. To search for grey literature, reference lists were searched and a total of five new articles were found, however, only three were able to be retrieved, hence, a total of 24 articles were available for quality appraisal. The screening for articles was performed by D.H. and independently verified by S.K.A.S. The 24 articles selected after full-length reading were subjected to quality appraisal to determine their validity. All 24 articles were accepted for inclusion in the review. Figure 1 shows the PRISMA flow chart of the screening and inclusion processes of the articles.

3.2. Characteristics of Included Studies

Overall, 24 studies that met the inclusion criteria were used for this review. A total of 54,224 parents were recruited as participants in all the studies and numbers ranged from 42 in the study of Niederhauser et al. [26] to 13,000 in the study of Busso et al. [27]. In almost all the studies, participants were reportedly mothers or caregivers of the children [7,9,12,13,15,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,43,44]. Two studies reportedly mentioned males as participants, Hofstetter et al. [39] reported a nearly even distribution of participants, male (1051) and females (1003) and Niederhauser et al. [26] reported only one male participant in their study.
Regarding the categorisation of the countries of the included studies, the World Bank income classification reveals that 5 studies [26,28,33,35,42] were conducted in high-income countries, while the remaining 19 were conducted in low- or middle-income countries. Additionally, based on the study’s inclusion criteria, 4 studies [13,15,43,44] were quasi-experimental, while the remaining 20 were randomized control trials. Of the 20 RCTs, 3 [30,31,41] were cluster randomized trials. The course of the intervention ranges from 3 months in the study of Kagucia et al. [38] to 16 months in the study of Hofstetter et al. [42]. Mobile phone Short Message Services are the most common intervention for all the studies. Details of the studies are presented in Table A1.

3.3. Risk of Bias

The risk of bias in the studies was assessed using two different methods based on their designs. PEDro and CCAT were used for RCTs and quasi-studies, respectively. A summary of the risk of bias of the included 20 RCT studies indicates that most of the studies were rated as good quality—16 (80%), 14 (70%) studies clearly described their concealment of allocation and in the majority of the studies, blinding could not be achieved. Almost all—18 (90%)—of the studies reported analyzing results using intention to treat. Quasi-experimental studies were all found to be of acceptable quality. The total score ranges from 73% [15] to 78% [43]. Refer to Table 2 and Table 3 for a detailed assessment of the risk of bias.

3.4. Findings from Meta-Analysis

Twenty-four studies were included in the review to evaluated parental reminder or recall strategies for improved immunisation. Out of the 24 studies, 19 [9,13,15,26,29,30,31,32,33,34,35,36,38,39,40,41,42,43,44] provided sufficient information and were therefore included for meta-analysis. The 19 studies assess five different parental reminder/recall strategies on two major immunisation outcomes: coverage and timeliness of immunisation among children.

3.4.1. Coverage of Immunisation

Figure 2 below shows the results of the meta-analysis of five different intervention on the coverage of immunisation in children. The interventions are SMS reminder and incentive, reminder SMS, Voice call, SMS delivered health education and Voice call with SMS reminder.

3.4.2. Timeliness of Immunisation

Figure 3 below shows the results of three different interventions on the timeliness of immunisation. The interventions are SMS reminder with incentive, SMS remiders and SMS delivered health education messages.
Three studies were found to provide sufficient information and analysed using meta-analysis regarding the influence of incentives on improving immunisation coverage. However, Gibson et al. [31] appeared twice because the study assessed the difference between two incentives for improved immunisation outcomes against the control, hence, making n = 4. The finding from the study indicates an odds ratio (OR) of 1.5 95% CI 1.238, 862, p ≥ 0.001, n = 4. With regards to the heterogeneity, the I2 was 0.000 indicating an absence of heterogeneity. It is important to note that all the studies are rated using PEDro to be of good quality except the study of Brownstone et al. [36], which was found to be of fair quality.
Regarding the influence of SMS reminders in improving immunisation coverage, ten studies were found to have sufficient information for meta-analysis. Of the ten studies, two were from high-income countries [26,33], and the remaining studies were from low- and middle-income countries. It is important to note that the studies were all rated as having “good” quality except Mekonnen et al. [9], which was found to be of excellent quality. The pooled effect of parental SMS reminder for improved immunisation coverage was (OR = 1.671, 95% CI 1.169, 2.390, p = 0.005, n = 10). This shows that SMS intervention is approximately 1.7 times more likely to improve immunisation coverage compared to the control group because the p-value is less than 0.05. The I2 was found to be 74.781 indicating large heterogeneity exists in the studies based on the rule of thumbs.
A significant effect was found on the effect of voice calls in improving immunisation coverage, the pooled effect of four studies analysed were (OR 4.752, 95% CI 1.846, 12.231, p = 0.001, n = 4). Voice call intervention was about five times more likely to improve immunisation coverage compared to the control group with standard practice. It is worth noting that the study of Kempe et al. [28] was of “fair quality”. Although the remaining three studies are of “good” quality, they are all conducted in the same country, Nigeria, a low- and middle-income country; hence its generalisation should be used with caution. Additionally, the I2 (93.746) indicates that a large level of heterogeneity exists.
With regards to the effectiveness of health education messages delivered through mobile SMS on immunisation coverage, a large level of heterogeneity was identified with the I2 value of 82.472. The pooled effect (OR 3.158, 95% CI 0.301, 33.121, p = 0.338, n = 2) of the meta-analysis shows that intervention improves immunisation coverage by 3.2 times compared to the control group. Although the intervention was found to have odds of about 3.2, it is not statistically significant because the p = value of 0.338 is greater than 0.05.
Lastly, the pooled effect of a combination of voice calls and SMS reminders shows that intervention improved coverage of immunisation with the odds of 3.025 compared to the control group. The pooled effect revealed (OR 3.025, 95% CI 1.211, 3.389, p = 0.007) and the I2 of 69.37 indicates that a moderate level of heterogeneity exists.
The effect of incentives on timely immunisation uptake was found to be statistically significant with the pooled effect of (OR 2.151, 95% CI 1.613, 2.867, p-value = 0.001). This means incentives can improve timely immunisation uptake by 2.1 times compared to standard routine care. The study of Gibson et al. [31] appeared twice because it assessed the effectiveness of two different (75KES and 200KES) incentives against control on the timeliness of immunisation. The heterogeneity level was found to be moderate as the I2 value was 55.089.
In assessing the effectiveness of parental reminder SMS on timely immunisation uptake, nine provided sufficient information and were analysed using meta-analysis. The heterogeneity as reported by I2 (72.687) was interpreted to be moderate based on the rule of thumb. The pooled effect of the results indicates that intervention was statistically significant and about 1.5 times more likely to improve timely immunisation uptake than the control group (OR 1.472 95% CI 1.164, 1.883, p = 0.001, n = 9). The quality assessment of the studies indicates that one [9] was assessed to be of excellent quality based on the PEDro tool, while the remaining studies are rated as good quality.
Lastly, the effect of health education messages on timely vaccination shows the following pooled size effect (OR 2.711 95% CI 1.387, 5.299, p = 0.004). As the p-value of 0.018 is less than 0.05, health education messages delivered through SMS are statistically significant in improving the timely vaccination of children. Additionally, because of OR 2.711, participants in the intervention group are likely to be 2.7 times timely to have their infants vaccinated on time compared to those in the control group. The I2 of the 0.000 was also reported indicating the absence of heterogeneity in the included studies.

3.5. Narrative Synthesis

Four studies [7,12,27,37] used different forms of interventions in assessing immunisation coverage and timeliness in their studies and therefore were narratively analysed. Of the four studies included in this section, all reported outcomes on immunisation coverage, while only two [12,37] reported outcomes on the timeliness of vaccination.

3.5.1. Coverage of Immunisation

The study of Busso et al. [27] targets a community outreach program conducted once a month for six months and shows a positive effect on immunisation coverage by increasing coverage of immunisation among the population by up to 4.6% when compared with untargeted community outreach. Another study conducted in India by Nagar et al. [7] assessed immunisation coverage between three different interventions. The effectiveness of using a pendant plus one voice call a day to the immunisation due date, pendant alone or the NFC stickers placed on the child’s home-based record were assessed. The results were 69.4, 57.4 and 58.7% for pendant with voice call, pendant only and NFC stickers, respectively, at the endpoint. This indicates that the use of a pendant with voice call can lead to an increase in immunisation coverage compared with an NFC sticker, with a percentage difference of 10.7 per cent between the pendant plus voice call group and the NFC sticker group. Additionally, Wallace et al. [12] compared the use of home-based records alone, home-based records with stickers and standard care on immunisation coverage. Results indicate that home-based record plus sticker group for DTPcv3 vaccination completion rate was (77%) compared with the control group (RR = 0.97, 95% CI: 0.90, 1.04), and HBR-only group for DTPcv3 (74%) compared with the control group (RR = 0.94, 95% CI: 0.87, 1.02). HBR + sticker vs. control (77 vs. 78%) (RR = 0.99, 95% CI: 0.98, 1.09), HBR-only vs. control 74% (RR = 0.96, 95% CI: 0.88, 1.05). These results show that both interventions were not statistically significant in improving immunisation coverage. Lastly, Siddiqi et al. [37] compared the effectiveness of two bracelets in improving immunisation coverage in Pakistan; the Alma Sana Bracelet and the Star Bracelet. Results of the interventions reveal that interventions were both effective but not significant for improved coverage of immunisation coverage of Penta 3 at 12 months is 84.3, 85.4 and 83.0% for Alma Sana Bracelet, Star Bracelet and the control group, respectively. While measles coverage at 12 months was 72.0, 70.5 and 68.5% for Alma Sana Bracelet, Star Bracelet and the control group, respectively. Although using culturally appropriate intervention was novel, it did not bring about significant change compared to the control group.

3.5.2. Timeliness of Immunisation

Regarding the timeliness of immunisation, two studies [7,12] were used to narratively analyse the impact of interventions on the timeliness of vaccination. In the study of Nagar et al. [7], the use of a pendant with voice call led to 69.4% of the study participants’ timely immunisation uptake compared to 58.7% in the NFC stickers of the control group. On the other hand, when the pendant was used alone, there was no significant difference in its use (57.4%) compared with the use of NFC stickers (58.7%). This could then be implied that the use of voice call in the pendant with voice call group brought about the impact witnessed in that study arm group. In the study of Wallace et al. [12], the timeliness of vaccination within 60 days for the home-based record plus sticker group was 32%, for the home-based record was 24%, and for the control, 23%. The percentage difference between the intervention groups compared to the control group was +8% and +9% for home-based record plus sticker and home-based record groups, respectively.

3.6. Cost Implication

The cost implications for implementing interventions were also reported in four studies [27,28,29,32]. The cost per child ranges from USD 0.0075 in the study of Ek-haguere et al. [40] to USD 10 in the study of Kempe et al. [28]. Only Kempe et al. [28] reported the cost implication in the developed country, while the remaining three studies [27,29,32] were from low- and middle-income countries. From the reports, the average cost of implementing a collaborative centralised call was USD 10. In developing countries, two interventions on SMS reminder cost ranges from USD 0.0075 to USD 0.99, which is an average of USD 0.50 per child. Targeted outreach was reported to cost USD 0.11 per additional child [27] while voice call message cost USD 0.015 per child [40].

3.7. Certainty of Evidence

Certainty of evidence was assessed using GRADEpro, result of the assessment indicates that certainty of the evidence for interventions on coverage of immunisation ranges from very low (SMS reminder) to moderate (incentive; voice call with SMS reminder). For timeliness of immunisation, certainty of evidence was moderate (incentive), very low (SMS reminder) and high (SMS health education). The detail of the assessment of certainty of evidence is shown in Table 4 and Table 5. For reporting bias, outcomes that could be assessed using the funnel plots were retrieved and visualised for reporting bias. The funnel plots are in Figure A1, Figure A2 and Figure A3.

4. Discussion

To address the persistently low coverage of immunisation, this review assessed the effect of parental strategies on improved immunisation outcomes. Twenty-four studies that met the inclusion criteria were at low risk for bias. The total number of parent–child pairs in the included studies was 54,224. Most of the studies were from low- and middle-income countries. This disparity in study location could be attributed to the fact that most hesitancy to vaccination is due to a lack of awareness of vaccine importance, mostly in low- and middle-income countries and the ceiling effect in high-income countries [47]. This might be the rationale that spurs more studies in developing compared to developed countries. Thirteen different parental strategies were assessed across the 24 included studies to determine the effect of such intervention on three key outcomes. The outcomes assessed were immunisation coverage, timeliness, and the cost implication of the interventions. The effects of these interventions are discussed under these themes.
Building a vaccination culture within the healthcare system and critical stakeholders such as parents is fundamental for improved outcomes and safe and effective vaccine delivery [48]. Over the years, different strategies have been adopted to improve immunisation coverage across the globe. Five interventions (mobile voice call, SMS reminder, use of incentives, SMS health education and a combination of voice call with SMS reminder) were evaluated using meta-analysis to determine the most effective strategy for improved immunisation coverage. Finding reveals that all interventions were statistically significant for improving immunisation coverage except for SMS health education. Although the pooled effect of SMS health education messages was found to have improved immunisation coverage among the study participants, it was not statistically significant. Therefore, to improve immunisation coverage, the meta-analysis results reveal that voice call produced the largest effect in improving immunisation coverage. The use of mobile phone voice calls was found to be approximately five times most likely to improve immunisation coverage compared to the control participants, and this effect was statistically significant. To determine how significant the intervention was, evidence has recommended using Hopkin’s scale for determining effect size in the odds ratio category, and an odds ratio of 4.752 is interpreted to have a moderate effect [45]. Hence it can be said that mobile voice calls to parents can moderately improve immunisation coverage. The certainty of evidence is rated low as such; the assessed result may be considerably different from the true effect. Additionally, large heterogeneity exists, this could be due to the differences in the included studies as seen in the wide dispersion of the confidence interval and the relative weight of the studies. Furthermore, this heterogeneity could be related to sampling error or low retention rate. Due to these reasons and the fact that three [15,30,44] of the four studies used to determine these effects were from one country (Nigeria); its interpretation and use should be performed with caution. This finding is contrary to that of Frascella et al. [49] who found that the use of email reminders improved immunisation uptake in their review. A contrary result was also shared by Balzarini et al. [50] who reported a moderate effect to exist for the use of personalized electronic health records for improved immunisation outcomes. Balzarini et al. [50] further reported that the effect is even more when the intervention was combined with digitalized health educational messages. From this, it could be deduced that when information communication gadgets are introduced into immunisation program implementations, it could improve outcomes by increasing vaccine use.
On the other hand, the use of SMS reminders to parents also showed promising results in improving coverage of immunisation with the odds of 1.7 times for the intervention compared to the control and was found to be statistically significant in producing a small effect based on Cohen’s scale [45]. Close observations to explain the disparity between the two significant findings reveals that of the nine studies used for the meta-analysis, only four [9,29,32,34] of the studies reported translating the messages sent to parents; the other five either used only English [26,44] or did not report translating [31,43]. This could have a significant effect on the outcome of individual studies. This position is supported by Cheung et al. [51], who reported the critical role of translating instruments for better validity.
Timely vaccination is increasingly seen as an essential indicator for preventing the needless death of children from vaccine-preventable death [9]. The meta-analysis of three methods was performed to determine the most effective method to enhance timely immunisation uptake. The interventions were: SMS reminders, incentives and the effect of health education delivered through SMS. The analysis indicates that immunisation educational messages sent to participants had more effect on the timely immunisation of children. This intervention produced the most significant effect for timely immunisation completion, indicating that participants engaged in this intervention are approximately 2.7 times more likely to complete their immunisation on time. Although this is significant, the effect size, when determined using Cohen’s scale [45], reveals a small effect. Although it was of small effect, it was however of high certainty indicating that the estimated results lie close to the true effect. Additionally, although it was found to have no significant heterogeneity and of high certainty, its use should also be used with caution because of the limited number of studies included in the meta-analysis. The finding corresponds to Galadima et al. [52], who found in their systematic review that health education to mothers on immunisation shows a significant effect on the immunisation outcome of children. To this end, evidence reveals that understanding risk associated with health care hesitancy of recommended counsel or intervention positively impacts service utilisation or compliance with clinical advice [53]. The result also supports the assertion of Balzarini et al. [50] who reveal in their systematic review that digitalised health education messages improve immunisation outcomes. It is also worth mentioning that the use of incentives also shows promising effects in this analysis. It could produce the desired effect if adequately harnessed, especially with increased incentive.
Other interventions not included in the meta-analysis were, using pendants with and without voice calls, home-based records with and without stickers, and Star and Alma Sana Bracelets. It is worth noting that some of these interventions significantly improved immunisation uptake but were not larger than the immunisation health information disseminated through mobile technology. Mobile technology has now opened up the space and offers an opportunity for improved communication between health practitioners and clients and is now being explored further for improved immunisation indicators [54,55]. Despite its demonstrated effectiveness here, it can be further enhanced to produce a larger impact by considering factors such as the appropriate timing, use of local languages to send messages and targeting the male partners in addition to women. Getting the male partner involved for improved immunisation outcomes is an assertion identified here that is yet to be explored.
Regarding cost implication, four studies reported the cost implication for the parental reminder. It is, however, essential to note that three of the four studies were conducted on cost analysis using the SMS reminder strategy in developing countries. A cost analysis of the studies indicates that, on average, USD 0.50 was used to implement an SMS call/recall intervention per child in LMICs. This finding proves that cheap and low-cost interventions can be implemented to improve immunisation coverage [56]. It is also worth noting that this intervention was found in this review to be effective with a moderate effect in improving immunisation coverage more than interventions with incentives. In addition, evidence reports that for every USD 1 spent to vaccinate a child, about USD 79 is saved [10]. This proves that SMS reminder/recall is a cost-effective intervention for improved immunisation coverage. However, using other technology (a centralised collaborative recall system) was found to cost an average of USD 10 for its intervention.

5. Implication

Policymakers can use the results of this review and apply them to their context by designing appropriate interventions such as health information using local languages for hard-to-reach populations to create more awareness and thereby reduce vaccine hesitancy. This can also help bridge the wide health inequality gap among the rural-urban population, thereby creating inclusion and increasing the use of vaccines.

6. Conclusions

This review was conducted to determine an effective strategy for enhanced timely immunisation and coverage. The findings of this review affirm the role of mHealth technology in delivering a cheap and efficacious health intervention for enhanced coverage and timeliness of immunisation. The study indicates that reminder voice calls and SMS-delivered health education improve immunisation outcomes. Though the effects of such interventions were moderate and small for coverage and timeliness, respectively, the researchers recommend that studies utilising mHealth should be explored more, especially on the influence of the male partners as a critical determinant to health service utilisation, especially in LMIC. Future studies should also consider determining the optimal dose required for the implementation of mHealth interventions for optimal vaccine coverage. Modules for mHealth health education could be developed that are population specific that can be used for mHealth educational interventions for improved vaccine use.
This study is limited because of the potential of excluding other studies for this review, such as articles not written in English, pilot studies and limiting the time for search to only eight years. Additionally, of the 24 included studies, only 5 were from HIC, and the other 19 were from LMICs; as such, interpretation of the findings in HICs should be made with caution. Due to heterogeneity and low certainty of evidence for intervention on improving coverage, the findings of the meta-analysis should also be interpreted with caution.

Author Contributions

Conceptualization, S.K.A.S. and H.D.; methodology, H.D. and S.K.A.S.; software, H.D.; validation, S.K.A.S. and K.T.R.; writing—original draft preparation, H.D.; editing, S.K.A.S. and K.T.R.; supervision, S.K.A.S. and K.T.R. All authors have read and agreed to the published version of the manuscript.

Funding

This publication is sponsored by Universiti Teknologi MARA and Fundamental Research Grant Scheme (FRGS) (ref: FRGS/1/2019/SS06/UITM/03/1).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data utilized for the purpose of this study are available publicly and online.

Acknowledgments

We acknowledge the contributions of Chutiyami Mohammed who provided free access to his subscribed Comprehensive Meta-Analysis software used for this analysis.

Conflicts of Interest

The authors declare no conflict of interest.

Appendix A

Table A1. Table of data extraction.
Table A1. Table of data extraction.
No.Author
(Year)
ParticipantsSample
Size
DesignInterventionControlVaccine typeCountryDoseInstrumentResults
Freq.Course
1Niederhauser et al. [26]Mothers422-arm RCTSMS reminder
n = 19
Usual/standard care n = 23DTaP, hepatitis B, Hib, PCV and polioUSA2 SMS sent at 4 and 2 weeks to the due dateSeven monthsVaccination recordsImmunisation coverage at seven months was 7 (41.2%) in the intervention group compared to 15 (65.2%) in the control group. This indicates that 58.8% and 34.8% were not up to date with immunisation at seven months.
2Kempe et al. [28]Mother–infant pair18,235RCTCollaborative centralized reminder/recall approach (n = 9049)Practice-based
reminder/recall approach
n = 9186
DPT, Poliovirus, measles, Hib, Hepatitis B, Varicella and PCV.United StatesAutodialled/mail protocol (2 calls or four mails followed by two postcards)
Mail only (1 letter and three postcards every six weeks)
6 MonthsImmunisation recordIntervention improves coverage by 26.9% for the collaborative centralized/recall approach treatment group compared to 21.7% for practice-based (p < 0.001).
3Hofstetter et al. [39]Mother–child pair2054RCTA. scheduling + appointment SMS reminder (n = 686)
B. appointment SMS reminder only n = 686
Usual care
n = 682
MMRUnited StatesThree schedules plus one SMS16 months1. Hospital vaccination record
2. Vaccine cards
The intervention led to timely uptake of MMR vaccination 686(61.1%) vs. 682 (55.1%) (RRR 1.11 95% CI 1.01–1.21). For the SMS and control arm, respectively.
4Bangure et al. [29]Mothers3042-arm RCTSMS reminder
n = 152
Usual health talk
n = 152
OPV, PCV and PentavalentZimbabweThree times per visit on days 7, 3 and 1 before each scheduled14 weeksImmunisation registerOn the 14th week, the intervention resulted in 82% of respondents receiving timely immunisation compared to only 8% in the control group. While at the 14th week, vaccination coverage was 95% and 75% for the intervention and control groups, respectively.
5Busso et al. [27]Mothers13,000RCTCommunity outreach with patients list requiring immunisationCommunity outreach without patients listBCG, Pentavalent, Poliovirus and MMRGuatemalaOnce a month6 MonthsHospital recordsImmunisation coverage increased by 4.6% among the intervention group The direct cost per child in the study was USD 0.11 per child for 6 months.
6Brown et al. [30]Mothers595RCTA. Telephone call: reminder/recall n = 148
B. PHCIPT n = 150
C. Combination of A and B n = 147
C. Usual care practice n = 150OPV, DPT, Hepatitis B, Measles and Yellow feverNigeriaA. Two reminder calls (on days 2 and 1 before due date) and recall four times
B. Two days of one-off training for RI providers
12 monthsAmerican Immunisation Registry
Association (AIRA) questionnaire
Coverage at the of the study was 98.6% for the voice call reminder or recall group compared to the control with coverage of 57.3%.
7Uddin et al. [43]Mothers1030Cluster quasi-experimentalMobile SMS in rural areas n = 520Mobile SMS in urban areas
n = 518
BCG, Pentavalent and MRBangladeshThree messages
One a day to the scheduled visit, in the morning of the opening hour of the clinic and two hours to the close of the clinic
12 monthsImmunisation register and mother’s recallRURAL COVERAGE The intervention increased coverage in rural areas from 58.9% to 76.8%, difference +18.8% (95% CI 5.7–31.9) URBAN COVERAGE Urban coverage improved from 40.7% to 57.1% with a difference of +16.5% (95% CI 3.9–29.0).
8Gibson et al. [31]Mother16004-arm cluster RCTA. SMS-only
n = 388
B. SMS+ 75 KES for each pentavalent received
n = 446
C. SMS+ 200 KES for each pentavalent received
n = 406
Usual care practice
n = 360
BCG, OPV, Pentavalent and MeaslesKenyaSMS reminder on days 3 and 1 before the immunisation due date12 monthsImmunisation registerFull immunisation coverage at 12 months of age for SMS-only group, 296 (82%) of 360 control group compared to intervention participants, 332 (86%) of 388. RR = 1.04 (95% CI 0.97–1.12). SMS plus 75 KES intervention group had achieved 86% compared to the control group that had 82%, control participants group. Intervention comparing higher incentive 200 KES in addition to SMS leads to 90% 364 of 406 participants achieving immunisation coverage compared to the control group that had 82%, participants group. SMS plus 75 KES on the timeliness of immunisation is 70%; RR 1.37 (95% CI 1.18–1.59) compared to the control group of 50% timely coverage. SMS plus 200 KES on the timeliness of immunisation is 72%; RR 1.42 (95% CI 1.23–1.65) compared to the control group of 50% timely coverage.
9Nagar et al. [7]Mothers1983-arm RCTA. Pendant with Voice Call arm (P + V). n = 75
B. Pendant only n = 61
Near Field Communication (NFC) stickers placed on the child immunisation card. n = 62DTPIndiaVoice call a day to due date and after the due date for no show180 days from birthImmunisation records and patient recallDPT3 completion within 2 months. Control NFC sticker 74.2%, pendant only 67.2% and pendant +voice call 69.3. DPT Shots within 180 days 69.4, 57.4 and 58.7% for pendant with voice call, pendant only and NFC stickers, respectively.
10Seth et al. [32]Mothers5493-arm RCTA. Automated SMS-only (n = 188)
B. Automated SMS with airtime for each received scheduled vaccine n = 179
Immunisation record cards (n = 182)OPV, Rotavirus, Pentavalent, PCV, IPV and MRIndiaOne (1) automated SMS sent before the scheduled due date12 monthsImmunisation recordsTimeliness of immunisation dropped in the SMS-only participants by 24.7% (60 out of 243) when compared to the standard treatment group, 31.3% (76 of 243)
Vaccination coverage for the control and intervention groups was 40.1% (Inter Quartile Range: 30.8–69.2%), and 50.0% (Inter Quartile Range: 30.8–76.9%), respectively.
The incentive-linked group achieved immunisation coverage of 50.0% interquartile range (IQR: 30.8–76.9%) compared to the control group of 41.7% (IQR: 23.1–69.2%).
40.8% of the SMS and incentive intervention group completed immunisation on time compared to 31.3% of the control group.
11O’Grady et al. [33]Mother1963-arm RCTA. Simple SMS. n = 64
B. educational
SMS ± additional support group ESMS±S
n = 65
Usual care practices n= 67HepB-DTPa_Hib_IPV, PCV and RotavirusAustraliaSMS sent 2 and 1 weeks before the due date and after two weeks if the child is still not vaccinatedEight monthsQuestionnaire and immunisation recordImmunisation coverage rose to 70.3% of 45/64 in the SMS intervention group compared to 67.2% 45/67 in the control arm.
At the end of the intervention, infants in the intervention group utilizing SMS-delivered educational messages had more vaccine coverage (83.1%) compared to the control group that received standard care 45/67 (67.2%).
12Kazi et al. [39]Caregiver3002-arm
RCT
SMS reminder
n = 150
Standard care practice
n = 150
DPT-Hep-B-Hib vaccine
OPV
PakistanFour SMS reminders sent on the week of the scheduled appointment18 weeksRecord14 weeks scheduled visit was 47 (31.3%) for the intervention group vs. 39 (26.0%) for the control group, p = 0.31). It is therefore not statistically significant.
13Ekhaguere et al. [40]Mothers6002-arm
RCT
Voice call message and SMS n = 171Standard care n = 140Pentavalent, OPV, Rota vaccine, PCV, Measles and Yellow fever.NigeriaTwo SMS or voice call at day two and one to the scheduled immunisation12 monthRecordAll scheduled immunisations collectively led to (57% vs. 47%, RR 1.13, 95% CI 1.02 to 1.26; p = 0.01) within 1 week of the recommended date for the intervention compared to the control group. The cost of delivering the SMS was USD 0.0075 and USD 0.015 for SMS and voice call, respectively.
14Dissieka et al. [41]Mothers15962-arm RCTVoice call and SMS n= 484Standard care
n = 302
Pentavalent,
MMR and Yellow fever immunisations
Côte d’IvoireOne SMS reminder and call and two recalls9 monthRecordsImmunisation coverage at 9 month were 484 (60.7%) for the intervention group compared to 302 (37.8%) for the control with the adjusted odds ratio of 4.52 (2.84–7.20).
15Domek et al. [34]Mothers720RCTSMS sent in local languages
n = 329
The usual practice of care using child card n = 333Pentavalent, PCV, IPV, OPV, RotavirusGuatemala3 SMS at 3, 2 and 1 day to the due dateEight monthsElectronic immunisation recordTimeliness at Visit 3 was found to be 112 (34.0%) of 329 for experimental group and 90 (27.0%) of 333 in the control group, p = 0.05.
Both intervention and control groups had a high rate of immunisation coverage (89.1% vs. 89.2%) for intention to treat analysis but were not statistically different.
16Wallace et al. [12]Mothers3616Cluster RCTA. Home base records (HBR) only. N = 1290
B. Home base record + stickers. n = 711
Routine care practice n = 1615DPTIndonesiaA. HBR provided whenever, missing, damaged or destroyed and information transferred to the new one.
B. In addition to A above, stickers are placed indicating due date for each immunisation visit.
7 months HBR + sticker group for DTPcv3 vaccination completion rate (77%) compared with the control group (81%) (RR = 0.97, 95% CI:0.90, 1.04), neither HBR-only group for DTPcv3 (74%) compared with the control group (RR = 0.94,95% CI:0.87, 1.02). HBR + sticker vs. control (77 vs. 78%) (RR = 0.99, 95% CI: 0.98, 1.09), HBR-only vs. control 74% (RR = 0.96, 95% CI: 0.88, 1.05) However, children in the HBR + sticker group were 50% more likely to.
17Menzies et al. [35]Mothers1594Four arm RCTA. SMS-only. (n = 398)
B. Personalized calendar (PC) only. n = 398 C. PC+ SMS.
n = 404
Usual care practice n= 394DPT, Polio, Hib, Rotavirus, Pnuemococcal, MMR and VaricellaAustralia2 SMS at 14 and 2 days to the due dateTen monthsExcel spreadsheet information extracted from immunisation registerResults on the 6th-month timely immunisation show 310 (78%) RR 1.05 (95% CI 0.97–1.14) SMS reminder intervention group had their children immunised on time compared to 291 (74%) of the control arm.
18Brownstone et al. [36]Mothers9513-arm RCTModel 1: higher incentive (baseline amount NGN 3000 + NGN 1000 a reminder call)
n = 345
Model 2: more minor incentive (baseline amount NGN 2000 + NGN 1000 plus a reminder call). n = 606BCG, Pentavalent, PCV and MeaslesNigeriaOne call or SMS before the scheduled date and an additional increase in incentiveFour monthsChild health record bookResults from the intervention show that increasing monetary intervention was effective in resulting in 90.1% coverage of measles vaccine compared to 86.1% recorded in the control group.
19Siddiqi et al. [37]Caregiver14453-arm RCTA. Alma Sana Bracelet Group
n = 482
B. Star Bracelet Group n = 482
Usual care practice
n = 481
Pentavalent and MeaslesPakistan6 punctures at the appropriate age or 6 crescent punctures before completion of vaccination. One per visit12 monthsHospital recordsCoverage of Penta 3 at 12 month is 84.3, 85.4, 83% for Alma Sana Bracelet, Star Bracelet and control group, respectively. While measles 1 coverage at 12 months was 72.0, 70.5 and 68.5% for Alma Sana Bracelet, Star Bracelet and control group, respectively.
20Mekonnen et al. [9]Mothers4262-arm RCTReminder SMS
n = 213
Usual care practice
n = 213
BCG, OPV, Rotavirus, Pentavalent, PCV, Rotavirus, Measles and Inactivated PolioEthiopia1 SMS sent a day to the due date12 monthsHospital recordTimely vaccination was 213 (63.3%) and 213 (39.9%) for experimental and control group, respectively p < 0.001; risk ratio 1.59, 95% lower CI: 1.35. While coverage was 82% of 176/213 compared to 70.9% of 151/213, respectively; p = 0.002; Risk Ratio 1.17, 95% lower CI 1.07) compared to those in the control group.
21Kagucia et al. [38]Caregivers5373-arm RCTA. SMS reminder
n = 146
B. SMS reminder+ monitory incentive (150KES) n = 149
Usual care practice
n = 160
Measles vaccineKenya2 SMS sent 3 and 1 day to the due date3 monthsChecklist and questionnaireSMS intervention yielded 146 (78%) timely completion against 160(68%) timely coverage in the control arm with adjusted RR 1.13; 95% CI 0.99 1.30; p = 0.070.
22Ibraheem et al. [44]Mothers5404-arm
Quasi-experimental
A. SMS reminder
n = 136
B. Phone call reminder
n = 133
C. SMS health education
n = 133
Routine care practice
n = 136
Pentavalent, PCV, OPV, IPV, Measles and Yellow feverNigeria1 SMS a day to the due dateFive monthsImmunisation register86 (63.7%) received timely the 9th-month immunisation schedule while the 45 (36.6) vaccines timely for the intervention and control arm, respectively, p < 0.001. Completion of immunisation at 9 months was higher among the SMS reminder group (99.3%) compared with the control group, with percentage coverage of 90.4%. Immunisation fact messages sent through SMS improved immunisation timeliness in the intervention group compared to the control group of 97% and 90.4%, respectively.
SMS conveyed health education messages yield 99.2% immunisation coverage compared to 90.4% in the standard care group. Coverage for phone call was 99.2% compared to control with coverage of 90.4%.
23Oladepo et al. [13]Mother–infant pair31392-arm quasi experimentalSMS on immunisation health education
n = 1479
Flyers on nutrition and growth monitoring
n = 1499
BCG, Pentavalent, OPV, HBV, IPV, Measles and Yellow feverNigeriaImmunisation education messages are sent three times a weekTen monthImmunisation registerSMS education messages led to a 76.0 vs. 73.3% completion rate in the control group with standard care.
24Yunusa et al. [15]Mothers5412-arm
Quasi
experimental
Mobile phone call reminder
n = 271
Routine care practice with child health card
n = 270
PentavalentNigeriaTwo calls on days 3 and 1 and call if the client fails to show upFour monthImmunisation registerThe coverage rate in the experimental group was 59.4% compared to the control group of 34.1% after four months of intervention.
Key: HepB-DTPa_Hib_IPV = (hepatitis B, diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type B, polio), MMR = Measles–mumps–rubella, IPV = Inactivated polio vaccine, OPV: Oral polio vaccine, DPT = Diptheria pertussis tetanus, BCG = Bacillus Calmette–Guérin vaccine against tuberculosis, MR = Measles–Rubella, PCV = Pneumococcal conjugate vaccine, SMS = Short Message Services, HBR = Home-Based Record, RCT = Randomised control trials, ESMS = Educational Short Message Services.
Table A2. Cohen’s Table of Effect Size.
Table A2. Cohen’s Table of Effect Size.
TrivialSmallModerateLargeVery LargeNearly PerfectPerfect
Correlation0.00.10.30.50.70.91
Difference in means0.00.20.61.22.04.0Infinite
Frequency difference01030507090100
Relative risk1.01.21.93.05.719Infinite
Odd ratio1.01.53.59.032360Infinite

Appendix B. Funnel Plots

Figure A1. Funnel plots on coverage.
Figure A1. Funnel plots on coverage.
Healthcare 10 01996 g0a1
Figure A2. SMS reminder timeliness.
Figure A2. SMS reminder timeliness.
Healthcare 10 01996 g0a2
Figure A3. SMS reminder on timeliness.
Figure A3. SMS reminder on timeliness.
Healthcare 10 01996 g0a3

References

  1. How Do Vaccines Work? Available online: https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work?adgroupsurvey={adgroupsurvey}&gclid=CjwKCAjw2rmWBhB4EiwAiJ0mtYOYzi0LnpL7VoX8xBEskri-Gg-l-oCgWzh2oV5EmyjlETgMZUbWKRoCMZYQAvD_BwE (accessed on 14 July 2022).
  2. Understanding How Vaccines Work. Available online: https://www.cdc.gov/vaccines/hcp/conversations/understanding-vacc-work.html (accessed on 14 July 2022).
  3. Das, J.K.; Salam, R.A.; Arshad, A.; Lassi, Z.S.; Bhutta, Z.A. Systematic Review and Meta-Analysis of Interventions to Improve Access and Coverage of Adolescent Immunizations. J. Adolesc. Health 2016, 59, S40–S48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Rodrigues, C.M.C.; Plotkin, S.A. Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiol. 2020, 11, 1526. [Google Scholar] [CrossRef] [PubMed]
  5. Lwembe, S.; Green, S.A.; Tanna, N.; Connor, J.; Valler, C.; Barnes, R. A Qualitative Evaluation to Explore the Suitability, Feasibility and Acceptability of Using a ‘Celebration Card’ Intervention in Primary Care to Improve the Uptake of Childhood Vaccinations. BMC Fam. Pract. 2016, 17, 1–11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Orenstein, W.A.; Ahmed, R. Simply Put: Vaccination Saves Lives. Proc. Natl. Acad. Sci. USA 2017, 114, 4031–4033. [Google Scholar] [CrossRef] [Green Version]
  7. Nagar, R.; Venkat, P.; Stone, L.D.; Engel, K.A.; Sadda, P.; Shahnawaz, M. A Cluster Randomized Trial to Determine the Effectiveness of a Novel, Digital Pendant and Voice Reminder Platform on Increasing Infant Immunization Adherence in Rural Udaipur, India. Vaccine 2018, 36, 6567–6577. [Google Scholar] [CrossRef]
  8. Use of Appropriate Digital Technologies for Public Health. Available online: https://apps.who.int/gb/ebwha/pdf_files/WHA71/A71_20-en.pdf (accessed on 27 July 2022).
  9. Mekonnen, Z.A.; Gelaye, K.A.; Were, M.; Tilahun, B. Effect of Mobile Phone Text Message Reminders on the Completion and Timely Receipt of Routine Childhood Vaccinations: Superiority Randomized Controlled Trial in Northwest Ethiopia. JMIR MHealth UHealth 2021, 9, e27603. [Google Scholar] [CrossRef]
  10. IVAC Identifies Solutions to Nigeria Childhood Mortality Crisis. Available online: https://www.gavi.org/news/media-room/ivac-identifies-solutions-nigeria-childhoodmortality-crisis (accessed on 18 July 2022).
  11. Garcia-Dia, M.J.; Fitzpatrick, J.J.; Madigan, E.A.; Peabody, J.W. Using Text Reminder to Improve Childhood Immunization Adherence in the Philippines. Comput. Inform. Nurs. 2017, 35, 212–218. [Google Scholar] [CrossRef]
  12. Wallace, A.S.; Peetosutan, K.; Untung, A.; Ricardo, M.; Yosephine, P.; Wannemuehler, K.; Brown, D.W.; McFarland, D.A.; Orenstein, W.A.; Rosenberg, E.S.; et al. Home-Based Records and Vaccination Appointment Stickers as Parental Reminders to Reduce Vaccination Dropout in Indonesia: A Cluster-Randomized Controlled Trial. Vaccine 2019, 37, 6814–6823. [Google Scholar] [CrossRef]
  13. Oladepo, O.; Dipeolu, I.O.; Oladunni, O. Outcome of Reminder Text Messages Intervention on Completion of Routine Immunization in Rural Areas, Nigeria. Health Promot. Int. 2021, 36, 765–773. [Google Scholar] [CrossRef]
  14. Oyo-Ita, A.; Wiysonge, C.S.; Oringanje, C.; Nwachukwu, C.E.; Oduwole, O.; Meremikwu, M.M. Interventions for Improving Coverage of Childhood Immunisation in Low- and Middle-Income Countries. Cochrane Database Syst. Rev. 2016, 7, CD008145. [Google Scholar] [CrossRef]
  15. Yunusa, U.; Ibrahim, A.H.; Ladan, M.A.; Gomaa, H.E.M. Effect of Mobile Phone Text Message and Call Reminders in the Completeness of Pentavalent Vaccines in Kano State, Nigeria. J. Pediatr. Nurs. 2022, 64, e77–e83. [Google Scholar] [CrossRef]
  16. Harvey, H.; Reissland, N.; Mason, J. Parental Reminder, Recall and Educational Interventions to Improve Early Childhood Immunisation Uptake: A Systematic Review and Meta-Analysis. Vaccine 2015, 33, 2862–2880. [Google Scholar] [CrossRef] [Green Version]
  17. Lukusa, L.A.; Ndze, V.N.; Mbeye, N.M.; Wiysonge, C.S. A Systematic Review and Meta-Analysis of the Effects of Educating Parents on the Benefits and Schedules of Childhood Vaccinations in Low and Middle-Income Countries. Hum. Vaccines Immunother. 2018, 14, 2058–2068. [Google Scholar] [CrossRef]
  18. Eze, P.; Lawani, L.O.; Acharya, Y. Short Message Service (SMS) Reminders for Childhood Immunisation in Low-Income and Middle-Income Countries: A Systematic Review and Meta-Analysis. BMJ Glob. Health 2021, 6, e005035. [Google Scholar] [CrossRef]
  19. Selçuk, A.A. A Guide for Systematic Reviews: PRISMA. Turk. Arch. Otorhinolaryngol. 2019, 57, 57–58. [Google Scholar] [CrossRef]
  20. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  21. Tawfik, G.M.; Dila, K.A.S.; Mohamed, M.Y.F.; Tam, D.N.H.; Kien, N.D.; Ahmed, A.M.; Huy, N.T. A Step by Step Guide for Conducting a Systematic Review and Meta-Analysis with Simulation Data. Trop. Med. Health 2019, 47, 46. [Google Scholar] [CrossRef]
  22. Matos, A.P.; Pegorari, M.S. How to Classify Clinical Trials Using the PEDro Scale? J. Lasers Med. Sci. 2020, 11, 1–2. [Google Scholar] [CrossRef] [Green Version]
  23. Summary of Measurement Properties of the PEDro Scale. PEDro. Available online: https://pedro.org.au/english/summary-of-measurement-properties-of-the-pedro-scale/ (accessed on 26 August 2022).
  24. Salihu, D.; Wong, E.M.L.; Bello, U.M.; Kwan, R.Y.C. Effects of Dance Intervention on Agitation and Cognitive Functioning of People Living with Dementia in Institutional Care Facilities: Systematic Review. Geriatr. Nurs. 2021, 42, 1332–1340. [Google Scholar] [CrossRef]
  25. Crowe Critical Appraisal Tool (CCAT) Form (v1.4). Available online: https://conchra.com.au/wp-content/uploads/2015/12/CCAT-form-v1.4.pdf (accessed on 26 July 2022).
  26. Niederhauser, V.; Johnson, M.; Tavakoli, A.S. Vaccines4Kids: Assessing the Impact of Text Message Reminders on Immunization Rates in Infants. Vaccine 2015, 33, 2984–2989. [Google Scholar] [CrossRef]
  27. Busso, M.; Cristia, J.; Humpage, S. Did You Get Your Shots? Experimental Evidence on the Role of Reminders. J. Health Econ. 2015, 44, 226–237. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kempe, A.; Saville, A.W.; Beaty, B.; Dickinson, L.M.; Gurfinkel, D.; Eisert, S.; Roth, H.; Herrero, D.; Trefren, L.; Herlihy, R. Centralized Reminder/Recall to Increase Immunization Rates in Young Children: How Much Bang for the Buck? Acad. Pediatr. 2017, 17, 330–338. [Google Scholar] [CrossRef] [PubMed]
  29. Bangure, D.; Chirundu, D.; Gombe, N.; Marufu, T.; Mandozana, G.; Tshimanga, M.; Takundwa, L. Effectiveness of Short Message Services Reminder on Childhood Immunization Programme in Kadoma, Zimbabwe—A Randomized Controlled Trial, 2013. BMC Public Health 2015, 15, 137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Brown, V.B.; Oluwatosin, O.A.; Akinyemi, J.O.; Adeyemo, A.A. Effects of Community Health Nurse-Led Intervention on Childhood Routine Immunization Completion in Primary Health Care Centers in Ibadan, Nigeria. J. Community Health 2016, 41, 265–273. [Google Scholar] [CrossRef]
  31. Gibson, D.G.; Ochieng, B.; Kagucia, E.W.; Were, J.; Hayford, K.; Moulton, L.H.; Levine, O.S.; Odhiambo, F.; O’Brien, K.L.; Feikin, D.R. Mobile Phone-Delivered Reminders and Incentives to Improve Childhood Immunisation Coverage and Timeliness in Kenya (M-SIMU): A Cluster Randomised Controlled Trial. Lancet Glob. Health 2017, 5, e428–e438. [Google Scholar] [CrossRef] [Green Version]
  32. Seth, R.; Akinboyo, I.; Chhabra, A.; Qaiyum, Y.; Shet, A.; Gupte, N.; Jain, A.K.; Jain, S.K. Mobile Phone Incentives for Childhood Immunizations in Rural India. Pediatrics 2018, 141, 2058–2068. [Google Scholar] [CrossRef] [Green Version]
  33. O’Grady, K.-A.F.; Kaus, M.; Jones, L.; Boddy, G.; Rablin, S.; Roberts, J.; Arnold, D.; Parfitt, S.; Johnston, R.; Hall, K.K.; et al. SMS Reminders to Improve the Uptake and Timeliness of the Primary Immunisation Series in Infants: A Multi-Centre Randomised Controlled Trial. Commun. Dis. Intell. 2022, 46, 1–19. [Google Scholar] [CrossRef]
  34. Domek, G.J.; Contreras-Roldan, I.L.; Bull, S.; O’Leary, S.T.; Bolaños Ventura, G.A.; Bronsert, M.; Kempe, A.; Asturias, E.J. Text Message Reminders to Improve Infant Immunization in Guatemala: A Randomized Clinical Trial. Vaccine 2019, 37, 6192–6200. [Google Scholar] [CrossRef]
  35. Menzies, R.; Heron, L.; Lampard, J.; McMillan, M.; Joseph, T.; Chan, J.; Storken, A.; Marshall, H. A Randomised Controlled Trial of SMS Messaging and Calendar Reminders to Improve Vaccination Timeliness in Infants. Vaccine 2020, 38, 3137–3142. [Google Scholar] [CrossRef]
  36. Brownstone, S.; Connor, A.; Stein, D. Improving Measles Vaccine Uptake Rates in Nigeria: An RCT Evaluating the Impact of Incentive Sizes and Reminder Calls on Vaccine Uptake. PLoS ONE 2020, 15, e0233149. [Google Scholar] [CrossRef]
  37. Siddiqi, D.A.; Ali, R.F.; Munir, M.; Shah, M.T.; Khan, A.J.; Chandir, S. Effect of Vaccine Reminder and Tracker Bracelets on Routine Childhood Immunization Coverage and Timeliness in Urban Pakistan (2017-18): A Randomized Controlled Trial. BMC Public Health 2020, 20, 1086. [Google Scholar] [CrossRef]
  38. Kagucia, E.W.; Ochieng, B.; Were, J.; Hayford, K.; Obor, D.; O’Brien, K.L.; Gibson, D.G. Impact of Mobile Phone Delivered Reminders and Unconditional Incentives on Measles-Containing Vaccine Timeliness and Coverage: A Randomised Controlled Trial in Western Kenya. BMJ Glob. Health 2021, 6, e003357. [Google Scholar] [CrossRef]
  39. Kazi, A.M.; Ali, M.; Zubair, K.; Kalimuddin, H.; Kazi, A.N.; Iqbal, S.P.; Collet, J.-P.; Ali, S.A. Effect of Mobile Phone Text Message Reminders on Routine Immunization Uptake in Pakistan: Randomized Controlled Trial. JMIR Public Health Surveill. 2018, 4, e20. [Google Scholar] [CrossRef]
  40. Ekhaguere, O.A.; Oluwafemi, R.O.; Badejoko, B.; Oyeneyin, L.O.; Butali, A.; Lowenthal, E.D.; Steenhoff, A.P. Automated Phone Call and Text Reminders for Childhood Immunisations (Primm): A Randomised Controlled Trial in Nigeria. BMJ Glob. Health 2019, 4, e001232. [Google Scholar] [CrossRef] [Green Version]
  41. Dissieka, R.; Soohoo, M.; Janmohamed, A.; Doledec, D. Providing Mothers with Mobile Phone Message Reminders Increases Childhood Immunisation and Vitamin A Supplementation Coverage in Côte d’Ivoire: A Randomised Controlled Trial. J. Public Health Afr. 2019, 10, 1032. [Google Scholar] [CrossRef]
  42. Hofstetter, A.M.; DuRivage, N.; Vargas, C.Y.; Camargo, S.; Vawdrey, D.K.; Fisher, A.; Stockwell, M.S. Text Message Reminders for Timely Routine MMR Vaccination: A Randomized Controlled Trial. Vaccine 2015, 33, 5741–5746. [Google Scholar] [CrossRef] [Green Version]
  43. Uddin, M.J.; Shamsuzzaman, M.; Horng, L.; Labrique, A.; Vasudevan, L.; Zeller, K.; Chowdhury, M.; Larson, C.P.; Bishai, D.; Alam, N. Use of Mobile Phones for Improving Vaccination Coverage among Children Living in Rural Hard-to-Reach Areas and Urban Streets of Bangladesh. Vaccine 2016, 34, 276–283. [Google Scholar] [CrossRef] [Green Version]
  44. Ibraheem, R.; Akintola, M.; Abdulkadir, M.; Ameen, H.; Bolarinwa, O.; Adeboye, M. Effects of Call Reminders, Short Message Services (SMS) Reminders, and SMS Immunization Facts on Childhood Routine Vaccination Timing and Completion in Ilorin, Nigeria. Afr. Health Sci. 2021, 21, 951–959. [Google Scholar] [CrossRef]
  45. Schäfer, T.; Schwarz, M.A. The Meaningfulness of Effect Sizes in Psychological Research: Differences between Sub-Disciplines and the Impact of Potential Biases. Front. Psychol. 2019, 10, 813. [Google Scholar] [CrossRef] [Green Version]
  46. Ahn, E.; Kang, H. Introduction to Systematic Review and Meta-Analysis. Korean J. Anesthesiol. 2018, 71, 103–112. [Google Scholar] [CrossRef]
  47. Chutiyami, M.; Wyver, S.; Amin, J. Are Parent-Held Child Health Records a Valuable Health Intervention? A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2019, 16, 220. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Pinkbook. CDC.gov. Available online: https://www.cdc.gov/vaccines/pubs/pinkbook/strat.html (accessed on 26 August 2022).
  49. Frascella, B.; Oradini-Alacreu, A.; Balzarini, F.; Signorelli, C.; Lopalco, P.L.; Odone, A. Effectiveness of email-based reminders to increase vaccine uptake: A systematic review. Vaccine 2020, 38, 433–443. [Google Scholar] [CrossRef] [PubMed]
  50. Balzarini, F.; Frascella, B.; Oradini-Alacreu, A.; Gaetti, G.; Lopalco, P.L.; Edelstein, M.; Azzopardi-Muscat, N.; Signorelli, C.; Odone, A. Does the use of personal electronic health records increase vaccine uptake? A systematic review. Vaccine 2020, 38, 5966–5978. [Google Scholar] [CrossRef] [PubMed]
  51. Cheung, H.; Mazerolle, L.; Possingham, H.P.; Tam, K.-P.; Biggs, D. A Methodological Guide for Translating Study Instruments in Cross-cultural Research: Adapting the ‘Connectedness to Nature’ Scale into Chinese. Methods Ecol. Evol. 2020, 11, 1379–1387. [Google Scholar] [CrossRef]
  52. Galadima, A.N.; Zulkefli, N.A.M.; Said, S.M.; Ahmad, N. Factors Influencing Childhood Immunisation Uptake in Africa: A Systematic Review. BMC Public Health 2021, 21, 1475. [Google Scholar] [CrossRef]
  53. Arlinghaus, K.R.; Johnston, C.A. Advocating for Behavior Change with Education. Am. J. Lifestyle Med. 2018, 12, 113–116. [Google Scholar] [CrossRef]
  54. Oliver-Williams, C.; Brown, E.; Devereux, S.; Fairhead, C.; Holeman, I. Using Mobile Phones to Improve Vaccination Uptake in 21 Low- and Middle-Income Countries: Systematic Review. JMIR MHealth UHealth 2017, 5, e148. [Google Scholar] [CrossRef]
  55. Dumit, E.M.; Novillo-Ortiz, D.; Contreras, M.; Velandia, M.; Danovaro-Holliday, M.C. The Use of EHealth with Immunizations: An Overview of Systematic Reviews. Vaccine 2018, 36, 7923–7928. [Google Scholar] [CrossRef]
  56. Munk, C.; Portnoy, A.; Suharlim, C.; Clarke-Deelder, E.; Brenzel, L.; Resch, S.C.; Menzies, N.A. Systematic Review of the Costs and Effectiveness of Interventions to Increase Infant Vaccination Coverage in Low- and Middle-Income Countries. BMC Health Serv. Res. 2019, 19, 741. [Google Scholar] [CrossRef]
Figure 1. PRISMA flow chart.
Figure 1. PRISMA flow chart.
Healthcare 10 01996 g001
Figure 2. Forest plot of interventions on immunisation coverage. (a) SMS reminder and incentive on coverage: Heterogeneity: Q-value = 2.051, p-value = 0.562, I-square 0.000 [31,32,36]. (b) Reminder SMS on coverage. Heterogeneity: Q = 35.13, p = 0.001, I-square = 74.381 [9,26,29,31,32,33,34,39,43,44]. (c) Voice call on coverage. Heterogeneity: Q-value = 47.973, p-value = 0.001, I-square 93.746 [15,30,32,42]. (d) SMS health education. Heterogeneity: Q-value = 5.705, p-value = 0.017, I-square 82.472 [13,44]. (e) Voice call and SMS on coverage. Heterogeneity: Q = 3.265, df = 1, p = 0.071, I2 = 69.37 [40,41].
Figure 2. Forest plot of interventions on immunisation coverage. (a) SMS reminder and incentive on coverage: Heterogeneity: Q-value = 2.051, p-value = 0.562, I-square 0.000 [31,32,36]. (b) Reminder SMS on coverage. Heterogeneity: Q = 35.13, p = 0.001, I-square = 74.381 [9,26,29,31,32,33,34,39,43,44]. (c) Voice call on coverage. Heterogeneity: Q-value = 47.973, p-value = 0.001, I-square 93.746 [15,30,32,42]. (d) SMS health education. Heterogeneity: Q-value = 5.705, p-value = 0.017, I-square 82.472 [13,44]. (e) Voice call and SMS on coverage. Heterogeneity: Q = 3.265, df = 1, p = 0.071, I2 = 69.37 [40,41].
Healthcare 10 01996 g002
Figure 3. Forest plot of interventions on timeliness. (a) SMS reminder and incentive on timeliness. Heterogeneity: Q-value = 4.453, p = 0.108, I-square 55.089 [31,32]. (b) SMS reminder. Heterogeneity: Q-value = 29.290, p = 0.001, I-square = 72.687 [9,29,31,32,34,35,38,42,44] (c) SMS health education on timeliness. Heterogeneity: Q-value = 0.246, p = 0.620, I-square = 0.000 [33,44].
Figure 3. Forest plot of interventions on timeliness. (a) SMS reminder and incentive on timeliness. Heterogeneity: Q-value = 4.453, p = 0.108, I-square 55.089 [31,32]. (b) SMS reminder. Heterogeneity: Q-value = 29.290, p = 0.001, I-square = 72.687 [9,29,31,32,34,35,38,42,44] (c) SMS health education on timeliness. Heterogeneity: Q-value = 0.246, p = 0.620, I-square = 0.000 [33,44].
Healthcare 10 01996 g003
Table 1. PICOS framework.
Table 1. PICOS framework.
No.VariableInclusion Criteria Exclusion Criteria
1PopulationParent of children Assess immunisation other than in children less than five years
2Intervention Parental reminder strategies for immunisation Intervention not targeting parents or caregivers of children less than five years
3Comparator Usual or standard care practice
4Outcome Immunisation coverage, timeliness and cost of interventionsOutcomes other than coverage, timeliness and cost of interventions
5Study design Randomised or quasi-experimental studiesSurvey, pilot study, non-peer review articles such as thesis
Table 4. Certainty of evidence for interventions on coverage of childhood immunisation.
Table 4. Certainty of evidence for interventions on coverage of childhood immunisation.
Certainty Assessment№ of PatientsEffectCertaintyImportance
No. of StudiesStudy DesignRisk of BiasInconsistencyIndirectnessImprecisionOther ConsiderationsIncentiveStandard CareRelative (95% CI)Absolute (95% CI)
Incentive on coverage of childhood immunisation
3Randomised trialsSerious aNot seriousNot seriousNot seriousNone1379/2884 (47.8%)1508/2884 (52.3%)OR 1.518 (1.238 to 1.862)102 more per 1000 (from 53 more to 148 more)⨁⨁⨁◯
Moderate
SMS Reminder on coverage of childhood immunisation
10Randomised trialsSerious aVery serious cNot seriousNot serious dNone2683/5334 (50.3%)2651/5334 (49.7%)OR 1.671 (1.169 to 2.390)126 more per 1000 (from 39 more to 206 more)⨁◯◯◯
Very low
Voice call on coverage of childhood immunisation
4Randomised trialsSerious aSerious cNot seriousNot seriousPublication bias strongly suspected e
strong association
9597/19339 (49.6%)9742/19339 (50.4%)OR 4.752 (1.846 to 12.231)325 more per 1000 (from 148 more to 422 more)⨁⨁◯◯
Low
SMS health education on coverage of childhood immunisation
2Randomised trialsNot seriousSerious fNot seriousSerious dNone1612/3247 (49.6%)1635/3247 (50.4%)OR 3.158 (0.301 to 33.121)259 more per 1000 (from 270 fewer to 468 more)⨁⨁◯◯
Low
Voice call and SMS reminder on coverage of childhood immunisation
2Randomised trialsSerious aSerious gNot seriousNot seriousStrong association601/1043 (57.6%)442/1043 (42.4%)OR 2.025 (1.211 to 3.389)174 more per 1000 (from 47 more to 290 more)⨁⨁⨁◯
Moderate
CI: confidence interval; OR: odds ratio; a No blinding; c heterogeneity and inconsistency in effect sizes; d wide confidence interval in studies with few sample size; e as shown on funnel plot; f wide variance and inconsistency in effect size; g heterogeneity.
Table 5. Certainty of evidence for interventions on timeliness of childhood immunisation.
Table 5. Certainty of evidence for interventions on timeliness of childhood immunisation.
Certainty AssessmentNo. of PatientsEffectCertaintyImportance
№ of StudiesStudy DesignRisk of BiasInconsistencyIndirectnessImprecisionOther ConsiderationsParental StrategiesStandard CareRelative (95% CI)Absolute (95% CI)
Incentive on timeliness of childhood immunisation
3Randomised trialsSerious aSerious bNot seriousNot seriousStrong association1031/1933 (53.3%)902/1933 (46.7%)OR 2.151 (1.613 to 2.867)186 more per 1000
(from 119 more to 248 more)
⨁⨁⨁◯
Moderate
SMS reminder on timeliness of childhood immunisation
9Randomised trialsSerious bSerious bNot seriousNot seriousPublication bias strongly suspected c2636/5248 (50.2%)2612/5248 (49.8%)OR 1.472 (1.164 to 1.863)96 more per 1000
(from 38 more to 151 more)
⨁◯◯◯
Very low
Health education on timeliness of childhood immunisation
2Randomised trialsSerious aNot seriousNot seriousNot seriousStrong association198/401 (49.4%)203/401 (50.6%)OR 2.711 (1.387 to 5.299)229 more per 1000
(from 81 more to 338 more)
⨁⨁⨁⨁
High
CI: confidence interval; OR: odds ratio; a no blinding; b heterogeneity; c as shown on funnel plot.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dathini, H.; Sharoni, S.K.A.; Robert, K.T. Parental Reminder Strategies and the Cost Implication for Improved Immunisation Outcomes: A Systematic Review and Meta-Analysis. Healthcare 2022, 10, 1996. https://doi.org/10.3390/healthcare10101996

AMA Style

Dathini H, Sharoni SKA, Robert KT. Parental Reminder Strategies and the Cost Implication for Improved Immunisation Outcomes: A Systematic Review and Meta-Analysis. Healthcare. 2022; 10(10):1996. https://doi.org/10.3390/healthcare10101996

Chicago/Turabian Style

Dathini, Hamina, Siti Khuzaimah Ahmad Sharoni, and Kever Teriyla Robert. 2022. "Parental Reminder Strategies and the Cost Implication for Improved Immunisation Outcomes: A Systematic Review and Meta-Analysis" Healthcare 10, no. 10: 1996. https://doi.org/10.3390/healthcare10101996

APA Style

Dathini, H., Sharoni, S. K. A., & Robert, K. T. (2022). Parental Reminder Strategies and the Cost Implication for Improved Immunisation Outcomes: A Systematic Review and Meta-Analysis. Healthcare, 10(10), 1996. https://doi.org/10.3390/healthcare10101996

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop